Although the current evidence is insufficient for p53 to be an independent prognostic marker, recent studies suggest that p53 overexpression might serve as a specific prognostic marker in a specific subgroup of patients with breast cancer [28, 29]. The gene discussed is TP53; the disease is breast carcinoma.